Ji Fang

164 LanXi Road
Shanghai, 200062, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Differences and significance of macrophage subtypes and regulatory T lymphocytes in the expression of interstitial fibrosis in diabetic nephropathy at different stages.

Differences and significance of macrophage subtypes and regulatory T lymphocytes in the expression of interstitial fibrosis in diabetic nephropathy at different stages.

Journal: BMC nephrology

Published: March 05, 2025

Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice.

Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice.

Journal: Inflammation

Published: October 20, 2024

Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment.

Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment.

Journal: Archives of pharmacal research

Published: March 25, 2024

Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.

Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.

Journal: Free radical biology & medicine

Published: January 03, 2023

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice.

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice.

Journal: Frontiers in pharmacology

Published: July 12, 2022

Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.

Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.

Journal: Journal of diabetes research

Published: October 18, 2021

Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.

Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.

Journal: BMC nephrology

Published: August 04, 2021

Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.

Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.

Journal: Biochemical and biophysical research communications

Published: October 17, 2020

Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.

Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.

Journal: Life sciences

Published: August 03, 2020

ApoL1 induces kidney inflammation through RIG-I/NF-κB activation.

ApoL1 induces kidney inflammation through RIG-I/NF-κB activation.

Journal: Biochemical and biophysical research communications

Published: March 25, 2020

Protective effects of probucol on Ox-LDL-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via LOX‑1/ROS/MAPK signaling.

Protective effects of probucol on Ox-LDL-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via LOX‑1/ROS/MAPK signaling.

Journal: Molecular medicine reports

Published: November 07, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026